Search
Press Releases
Search Archive:  

 

US Stem Cell Market Poised for Growth

Jun 05, 2009
Share |
 

The stem cell product market in US is expected to grow at a CAGR of 84% during 2009-2012 to reach at around US$ 889 Million by 2012, says a new report "US Stem Cell Market Analysis" from RNCOS.

The optimistic approach of the patients suffering from severe diseases towards the adoption of stem cell technology will fuel the growth of the stem cell market in future. Also, the rise in healthcare spending, with large part of the population without any health insurance cover, is making the costly treatments unfavorable for the Americans.

The US soon realized the hidden potential in stem cell market and took timely moves to ensure stem-cell storage that led to the development of therapeutic banking technology segment. The country therefore is backed up with adequate infrastructure to support the use of stem cells for therapy and research purposes.

The country has achieved some important milestones in the therapy areas like bone marrow transplantation with the help of stem cell technology. The cellular therapeutics though smaller in size than therapeutics banking market is expected to grow comparatively fast during 2009-2012.

The US stem cell market presently has few orthopedic products. However, seeing its efficacy to cure a problem over the present available treatments, researches are going on to find out new therapeutic applications.

The market is also expected to witness a robust growth with the easing-off of the regulatory constraints and federal funding in 21 different embryonic stem cell lines. The embryonic stem cells have the ability to convert into different types of tissues in the body and thus, they exhibit higher potential to cure a disease.

Our report "US Stem Cell Market Analysis" provides the rational analysis and extensive research on the stem cell market in the US. The report thoroughly examines the current industry trends which are adding to the growth in the country's stem cell market. The report also highlights various emerging therapy segments and their market potential to serve the population of the country more effectively.

For more information visit: http://www.rncos.com/Report/IM191.htm


Related Press Releases:
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
» US Drug Spending – Reaching Soaring Rates
» Global Genetic Testing Market worth US$ 1.5 Billion, to Grow Significantly
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL | FAQ | Upcoming Reports
Copyright © 2012, RNCOS, 2002-2012
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707